

![]() |
Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics |
|
Authors | ![]() | |
Published in | Alzheimer's & dementia. 2015, vol. 11, no. 10, p. 1191-1201 | |
Abstract | Proposed diagnostic criteria (international working group and National Institute on Aging and Alzheimer's Association) for Alzheimer's disease (AD) include markers of amyloidosis (abnormal cerebrospinal fluid [CSF] amyloid beta [Aβ]42) and neurodegeneration (hippocampal atrophy, temporo-parietal hypometabolism on [18F]-fluorodeoxyglucose-positron emission tomography (FDG-PET), and abnormal CSF tau). We aim to compare the accuracy of these biomarkers, individually and in combination, in predicting AD among mild cognitive impairment (MCI) patients. | |
Identifiers | PMID: 25646957 | |
Full text | ||
Structures | ||
Research group | Troubles de mémoire et maladie d'Alzeimer (935) | |
Citation (ISO format) | PRESTIA, Annapaola et al. Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics. In: Alzheimer's & dementia, 2015, vol. 11, n° 10, p. 1191-1201. doi: 10.1016/j.jalz.2014.12.001 https://archive-ouverte.unige.ch/unige:75892 |